Widespread use of complementary and alternative medicine among non-Hodgkin lymphoma survivors

Osian, Sarah Rausch; Leal, Alexis D.; Allmer, Cristine; Maurer, Matthew J.; Nowakowski, G. S.; Inwards, David J.; Macon, William R.; Ehlers, Shawna L.; Weiner, George J.; Habermann, Thomas M.; Cerhan, James R.; Thompson, Carrie A.

doi:10.3109/10428194.2014.916803

Cited by 15 publications

(15 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The use of complementary and alternative medicine (CAM) including relaxation techniques is growing in popularity, and it is reported that cancer survivors are more likely to use CAM than the general population [44]. Up to 89% of survivors report the use of CAM including mind-body approaches such as relaxation [45,46], choosing to do so without being advised by a healthcare professional. Hence, a proportion of cancer and lymphoma survivors may have a preference for relaxation programmes.…”

Section: Discussionmentioning

confidence: 99%

Relaxation versus exercise for improved quality of life in lymphoma survivors—a randomised controlled trial

et al. 2020

View full text Add to dashboard Cite

Purpose Lymphoma survivors experience persisting needs as a consequence of disease and treatment, which have an impact on quality of life (QoL). There is evidence supporting the use of relaxation and exercise to improve QoL, but there is no agreement on which is more beneficial. This study aims to compare a relaxation intervention versus an exercise intervention to determine which has a greater impact on QoL post-chemotherapy. Methods Eligible participants (n = 46) were randomised to a relaxation or exercise intervention for 12 weeks. QoL was assessed at baseline, 6 weeks and post-intervention using the European Organisation for Research and Treatment of Cancer QoL Questionnaire Core 30 (EORTC QLQ-C30) questionnaire, which is a valid and reliable tool. The summary score and all EORTC domains were assessed. Results There was a significant difference in QoL post-intervention between groups (p = 0.029) while adjusting for baseline QoL, with the exercise group demonstrating a larger improvement. Within-group QoL significantly improved pre- to post-intervention in both the relaxation (p = 0.036) and exercise (p = 0.004) groups. Conclusions A self-management intervention of either exercise or relaxation can help significantly improve QoL in lymphoma survivors following chemotherapy. While exercise is preferred, a relaxation intervention would also have a beneficial impact on QoL. Implications for Cancer Survivors Lymphoma survivors should be routinely screened and those with decreased QoL referred for an exercise programme, or relaxation for survivors who are unable to exercise or choose not to. A home-based programme can have a significant positive impact on QoL and is a feasible and effective method in the current climate. Trial registration number Clinical Trials ID NCT02272751

show abstract

Section: Discussionmentioning

confidence: 99%

Relaxation versus exercise for improved quality of life in lymphoma survivors—a randomised controlled trial

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Other studies, however, have shown an association between T&CM use and patients' factors, including age and education attainment. A study at the Mayo clinic showed that participants who use complementary and alternative medicines (CAM) were more likely to be female and older (>60 years; Rausch Osian, ). Similarly, it was shown in a multinational study in Europe, that CAM users were more likely to be younger, female and with a higher educational level (Molassiotis et al, ).…”

Section: Discussionmentioning

confidence: 99%

Use of traditional and complementary medicines by cancer patients at a national cancer referral facility in a low‐income country

2019

View full text Add to dashboard Cite

Objective The aim of this study was to describe use of traditional and complementary medicines (T&CM) and associated factors among patients with cancer. Methods We conducted a cross‐sectional study at the Uganda Cancer Institute (UCI) involving patients with selected solid tumours. Independent variables included age, sex, marital status, cancer site and stage. Main outcome variables were use and disclosure of use of T&CM. Results The majority of participants were women (n = 352; 81.9%). Breast cancer (n = 312; 71.9%) was the predominant cancer type. 55.4% of participants (n = 240) self‐reported use of T&CM. Among them, 68.3% (140/205) reported using them to treat/cure cancer, 35.6% (72/202) for strengthening the immune system and 31.2% (63/202) for management of pain. Patients with advanced stage cancers were more likely to be users compared with those in stage one. The majority (81.9%, 195/238) of T&CM users did not disclose use to their healthcare professionals. The main reasons for nondisclosure included lack of inquiry by clinicians (79.6%, 117/147) and fear of disapproval and/or rebuke (11.6%, 17/147). Conclusion Use of T&CM by patients with cancer under biomedical care is common but often undisclosed to the healthcare professionals.

show abstract

“…Several studies have identified and documented the clinical (cancer disease) and individual (demographic) factors associated with the usage of herbal medicine in cancer. Numerous factors have been positively correlated with herbal medicine use in cancer, such as young age, high education level, high-income level, ethnicity, female gender, cancer diagnosis, longer survival period since cancer diagnosis, receiving single or multiple cancer chemotherapies, being married, completion of conventional cancer treatment, having certain cancer symptoms, cancer metastasis, and belonging to specific social groups [22][23][24][25][26][27]. However, old age, being a child, having cancer comorbidities, place of residence, and the experience of chemotherapeutic side effects are negatively associated with herbal medicine use in cancer [16,26,28].…”

Section: Introductionmentioning

confidence: 99%

Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis

Asiimwe

Nagendrappa

Atukunda

et al. 2021

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

Background. Although herbal medicines are used by patients with cancer in multiple oncology care settings, the magnitude of herbal medicine use in this context remains unclear. The purpose of this review was to establish the prevalence of herbal medicine use among patients with cancer, across various geographical settings and patient characteristics (age and gender categories). Methods. Electronic databases that were searched for data published, from January 2000 to January 2020, were Medline (PubMed), Google Scholar, Embase, and African Index Medicus. Eligible studies reporting prevalence estimates of herbal medicine use amongst cancer patients were pooled using random-effects meta-analyses. Studies were grouped by World Bank region and income groups. Subgroup and meta-regression analyses were performed to explore source of heterogeneity. Results. In total, 155 studies with data for 809,065 participants (53.95% female) met the inclusion criteria. Overall, the pooled prevalence of the use of herbal medicine among patients with cancer was 22% (95% confidence interval (CI): 18%–25%), with the highest prevalence estimates for Africa (40%, 95% CI: 23%–58%) and Asia (28%, 95% CI: 21%–35%). The pooled prevalence estimate was higher across low- and middle-income countries (32%, 95% CI: 23%–42%) and lower across high-income countries (17%, 95% CI: 14%–21%). Higher pooled prevalence estimates were found for adult patients with cancer (22%, 95% CI: 19%–26%) compared with children with cancer (18%, 95% CI: 11%–27%) and for female patients (27%, 95% CI: 19%–35%) compared with males (17%, 95% CI: 1%–47%). Conclusion. Herbal medicine is used by a large percentage of patients with cancer use. The findings of this review highlight the need for herbal medicine to be integrated in cancer care.

show abstract

Widespread use of complementary and alternative medicine among non-Hodgkin lymphoma survivors

Cited by 15 publications

References 29 publications

Relaxation versus exercise for improved quality of life in lymphoma survivors—a randomised controlled trial

Relaxation versus exercise for improved quality of life in lymphoma survivors—a randomised controlled trial

Use of traditional and complementary medicines by cancer patients at a national cancer referral facility in a low‐income country

Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis

Contact Info

Product

Resources

About